Delivery of nitric oxide with a pH-responsive nanocarrier for the treatment of renal fibrosis-Reference-Cited by-同舟云学术

Delivery of nitric oxide with a pH-responsive nanocarrier for the treatment of renal fibrosis

Published:2023-02 Issue: Volume:354 Page:417-428
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Lee Tsung-Ying,Lu Hung-Hsun,Cheng Hui-Teng,Huang Hsi-Chien,Tsai Yun-Jen,Chang I-Hsiang,Tu Chao-Peng,Chung Chieh-Wei,Lu Tsai-Te,Peng Chi-How,Chen Yunching

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference51 articles.

1. Fibrosis—a common pathway to organ injury and failure;Rockey;N. Engl. J. Med.,2015

2. Cellular and molecular mechanisms of renal fibrosis;Liu;Nat. Rev. Nephrol.,2011

3. Chronic Kidney Disease;Webster;Lancet,2017

4. The global burden of chronic kidney disease: estimates, variability and pitfalls, Nature reviews;Glassock;Nephrology,2017

5. Renal fibroblasts and myofibroblasts in chronic kidney disease;Strutz;J. Am. Soc. Nephrol.,2006

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The influence of exogenous and endogenous nitric oxide on the human and animal body;PULMONOLOGIYA;2024-06-23

2. Elucidating the Molecular Pathways and Therapeutic Interventions of Gaseous Mediators in the Context of Fibrosis;Antioxidants;2024-04-25

3. Engineered liposomes targeting hepatic stellate cells overcome pathological barriers and reverse liver fibrosis;Journal of Controlled Release;2024-04

4. Mechanistic and Kinetic Insights into Cellular Uptake of Biomimetic Dinitrosyl Iron Complexes and Intracellular Delivery of NO for Activation of Cytoprotective HO-1;JACS Au;2024-03-29

5. Mitochondria-targeted NO donor enables synergistic NO and photodynamic therapies for effective inhibition of cancer cell proliferation and migration;Dyes and Pigments;2024-01